Summary
Results of a subgroup analysis from the JUPITER trial [NCT00239681] showed a significant reduction in major cardiovascular (CV) events in older, apparently healthy individuals who were treated with rosuvastatin compared with placebo.
- Lipid Disorders
- Prevention & Screening Clinical Trials
- © 2009 MD Conference Express
Tools
JUPITER Subgroup Analysis Provides Convincing Evidence for Statin Therapy as Primary Prevention for CV Events in Older Individuals
Permalink:
Table of contents
Cited By...
- No citing articles found.